EDIT Q4 2019 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena

EDITEditas Medicine, Inc.

$260M

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$12M+100.8% YoY

Gross Profit

-$23M-183.2% margin

Operating Income

-$39M-320.9% margin

Net Income

-$38M-307.5% margin

EPS (Diluted)

$-0.74

QoQ Revenue Growth

+219.2%

Cash Flow

Operating Cash Flow

$41M

Free Cash Flow

$39M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$509M

Total Liabilities

$246M

Stockholders' Equity

$262M

Cash & Equivalents

$238M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$6M	+100.8%
Gross Profit	-$23M	-$27M	+15.4%
Operating Income	-$39M	-$26M	-50.2%
Net Income	-$38M	-$25M	-50.8%